Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can have multiple pulmonary implications, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), and microscopic polyangiitis (MPA). This activity will provide pulmonologists—who serve as sentinel members of the multidisciplinary AAV management team—with a data-driven appraisal of new therapies, as well as established and emerging placement of these new therapies within the treatment paradigm. The activity will include a dynamic lecture, interactive case studies, and Q&A with pulmonologists who actively treat patients with MPA, GPA, and EGPA.

• Differentiate the etiology, clinical features and symptoms of the three types of AAV.
• Analyze cases to Illustrate the role of pulmonologists on the patient care team
• Outline a treatment algorithm for effective implementation using those cases

This activity is supported by an educational grant from AstraZeneca.